ID   BC12
AC   CVCL_U335
SY   BC-12; BC12TC
DR   TKG; TKG 0121
DR   Wikidata; Q54795206
RX   PubMed=381090;
RX   PubMed=3918910;
RX   PubMed=7721336;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
RX   PubMed=381090; DOI=10.20772/cancersci1959.70.3_305;
RA   Hashimoto Y., Kitagawa H.S.;
RT   "Antigen characteristics of nitrosamine-induced urinary bladder cancer
RT   in rats.";
RL   Gann 70:305-314(1979).
//
RX   PubMed=3918910; DOI=10.20772/cancersci1985.76.1_53;
RA   Hojo H., Endoh Y.S., Hashimoto Y.;
RT   "Cytotoxic lymphocytes in rat tumor in situ: effect of intraperitoneal
RT   injections of Propionibacterium avidum.";
RL   Jpn. J. Cancer Res. 76:53-60(1985).
//
RX   PubMed=7721336; DOI=10.1016/0165-2478(94)90226-7;
RA   Hojo H., Kaneko A., Kayagaki N., Saki M., Hashimoto Y.;
RT   "Subcellular localization and characterization of interleukin-1 alpha
RT   produced by rat bladder cancer cells.";
RL   Immunol. Lett. 43:215-220(1994).
//